Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/16/11 → 12/31/13 |
Funding
- Novartis (domestic): $130,969.00
Effects of Zortress® + Tacrolimus (everolimua) versus Standard Immunosuppression therapy on Progression of Coronary Artery Calcifications in Patients with Renal Transplantation
- Malluche, Hartmut (PI)
- Gedaly, Roberto (CoI)